Video Shorts

1:08
Market Watch Rx: Johnson & Johnson Shares Slide
5 months ago
by
Nicholas Jacobus

0:40
Real Hope: The Best Part of Being an Oncologist
5 months ago
by
Nicholas Jacobus(+1 more)

0:46
How Platform Technologies and Partnerships are Shaping CGT Development
5 months ago
by
Mike Hollan(+1 more)

0:43
Branding's Hidden Power
5 months ago
by
Michael Christel(+1 more)

1:09
Market Watch Rx: Roche Joins Top Gainers
5 months ago
by
Nicholas Jacobus

0:42
Addressing the Biosimilar Void in the U.S. Market
5 months ago
by
Mike Hollan(+1 more)

1:13
Market Watch Rx: Humana Leads Gainers
5 months ago
by
Nicholas Jacobus

0:40
The Relationship Between Muscle Building and GLP-1s
5 months ago
by
Mike Hollan(+1 more)

0:56
Drug Policy Shift: MFN's Impact on Providers
6 months ago
by
Mike Hollan(+1 more)

0:50
The Weird Connection Between Cancer and Heart Attacks
6 months ago

1:01
Market Watch Rx: Merck Joins Top Gainers
6 months ago
by
Nicholas Jacobus

0:50
Why China’s R&D Model is Thriving
6 months ago
by
Michael Christel(+2 more)

0:34
Takeaways from Day One at Access USA 2026
6 months ago
by
Nicholas Jacobus(+1 more)

1:01
Market Watch Rx: Intellia Therapeutics Leads Gainers
6 months ago
by
Nicholas Jacobus

1:08
What You Need to Know: MFN, Healthcare Spending, and Compounded Medications
6 months ago
by
Mike Hollan

0:42
What Can Help Patient Support Operations?
6 months ago
by
Nicholas Jacobus(+1 more)

1:41
2026 Drug Pipeline Report
6 months ago
by
Michael Christel

0:51
Measuring Good Patient Access from Bad Patient Access
6 months ago
by
Nicholas Jacobus(+1 more)

0:30
Can't Afford Your Meds? Watch This
6 months ago
by
Nicholas Jacobus(+1 more)

1:05
Market Watch Rx: Pfizer Joins Top Gainers
6 months ago
by
Nicholas Jacobus

1:03
Measuring the AI Bubble
6 months ago
by
Michael Christel(+2 more)

0:59
Market Watch Rx: IQVIA Joins Top Gainers
7 months ago
by
Nicholas Jacobus

0:53
FDA Drops Two-Trial Rule for New Drugs
7 months ago
by
Nicholas Jacobus(+1 more)

0:51
Market Watch Rx: Moderna Remains Amongst Top Gainers
7 months ago
by
Nicholas Jacobus

0:38
Europe’s Innovation Edge?
7 months ago
by
Michael Christel(+1 more)

0:53
Future of Healthcare: Hybrid Drug Payment System
7 months ago
by
Nicholas Jacobus(+1 more)

1:03
Market Watch Rx: Moderna Leads Gainers
7 months ago
by
Nicholas Jacobus

0:53
The State of Pharma TV Advertising
7 months ago
by
Mike Hollan(+1 more)

1:08
Market Watch Rx: AstraZeneca Among Top Gainers
7 months ago
by
Nicholas Jacobus

1:05
The EQ Imperative for Life Science CEOs
7 months ago
by
Michael Christel(+1 more)
Advertisement
Advertisement
Trending on PharmExec
1
CagriSema Tops Eli Lilly's Tirzepatide for Weight Loss in Late-Stage Diabetes Trial: Report
2
Understanding the Latest with MFN Pricing and What It Means to Pharma
3
FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A
4
The Battle to Own the GLP-1 Patient Journey
5
